The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Lam, C.-W. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg243 · Cited by 1,991
Torre, L. A., Siegel, R. L., & Jemal, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-24223-1_1 · Cited by 1,903
Comparative Pulmonary Toxicity Assessment of Single-wall Carbon Nanotubes in Rats
Warheit, D. B. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg228 · Cited by 1,515
Progress in applications of magnetic nanoparticles in biomedicine
Pankhurst, Q. A., Thanh, N. T. K., Jones, S. K., & Dobson, J. (2009) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/42/22/224001 · Cited by 1,455
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Biological applications of quantum dots
Jamieson, T., Bakhshi, R., Petrova, D., Pocock, R., Imani, M., & Seifalian, A. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.014 · Cited by 1,107
Lung cancer: Biology and treatment options
Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y.-W., & Buchanan, P. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.002 · Cited by 1,014
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Carbon nanotubes as nanomedicines: From toxicology to pharmacology☆
LACERDA, L., BIANCO, A., PRATO, M., & KOSTARELOS, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.015 · Cited by 839
Nanoparticles: pharmacological and toxicological significance
Medina, C., Santos‐Martinez, M. J., Radomski, A., Corrigan, O. I., & Radomski, M. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707130 · Cited by 738
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
Bermudez, E., Mangum, J. B., Wong, B. A., Asgharian, B., Hext, P. M., Warheit, D. B., & Everitt, J. I. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh019 · Cited by 652
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 651
Self-citationWarheit, D. B., Webb, T. R., Reed, K. L., Frerichs, S., & Sayes, C. M. (2007) · Toxicology · doi:10.1016/j.tox.2006.11.002 · Cited by 644
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Polymeric Conjugates for Drug Delivery
Larson, N., & Ghandehari, H. (2012) · Chemistry of Materials · doi:10.1021/cm2031569 · Cited by 580
Warheit, D. B., Webb, T. R., Sayes, C. M., Colvin, V. L., & Reed, K. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj140 · Cited by 508
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 454
Nanoparticles for biomedical imaging
Nune, S. K., Gunda, P., Thallapally, P. K., Lin, Y.-Y., Laird Forrest, M., & Berkland, C. J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903229031 · Cited by 450
Biotransformation of Xenobiotics
Timbrell, J. A., & Marrs, T. C. (2009) · General, Applied and Systems Toxicology · doi:10.1002/9780470744307.gat004 · Cited by 435
Advanced drug delivery systems: Nanotechnology of health design A review
Safari, J., & Zarnegar, Z. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2012.12.009 · Cited by 429
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Targeted delivery of magnetic aerosol droplets to the lung
Dames, P., Gleich, B., Flemmer, A., Hajek, K., Seidl, N., Wiekhorst, F., Eberbeck, D., Bittmann, I., Bergemann, C., Weyh, T., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.217 · Cited by 382
Lung cancer epidemiology: contemporary and future challenges worldwide
Didkowska, J., Wojciechowska, U., Mańczuk, M., & Łobaszewski, J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.11 · Cited by 380
Nanotechnology approaches for inhalation treatment of lung diseases
Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 352
Human respiratory epithelial cell culture for drug delivery applications
Forbes, B., & Ehrhardt, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.010 · Cited by 306
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin
Subedi, R. K., Kang, K. W., & Choi, H.-K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.008 · Cited by 301
Mercer, R. R., Scabilloni, J., Wang, L., Kisin, E., Murray, A. R., Schwegler-Berry, D., Shvedova, A. A., & Castranova, V. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00186.2007 · Cited by 291
Chitosan-graft-polyethylenimine as a gene carrier
Jiang, H.-L., Kim, Y.-K., Arote, R., Nah, J.-W., Cho, M.-H., Choi, Y.-J., Akaike, T., & Cho, C.-S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.025 · Cited by 289
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
Hirsch, F. R., Varella-Garcia, M., & Cappuzzo, F. (2009) · Oncogene · doi:10.1038/onc.2009.199 · Cited by 273
Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics
Liang, R., Wei, M., Evans, D. G., & Duan, X. (2014) · Chem. Commun. · doi:10.1039/c4cc03118k · Cited by 262
Tseng, C.-L., Su, W.-Y., Yen, K.-C., Yang, K.-C., & Lin, F.-H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.010 · Cited by 260
Magnetic core-shell nanoparticles for drug delivery by nebulization
Verma, N. K., Crosbie-Staunton, K., Satti, A., Gallagher, S., Ryan, K. B., Doody, T., McAtamney, C., MacLoughlin, R., Galvin, P., Burke, C. S., et al. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-1 · Cited by 260
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy
Sadhukha, T., Wiedmann, T. S., & Panyam, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.061 · Cited by 250
Taratula, O., Garbuzenko, O. B., Chen, A. M., & Minko, T. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.622404 · Cited by 245
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals
Patton, J. S., Brain, J. D., Davies, L. A., Fiegel, J., Gumbleton, M., Kim, K.-J., Sakagami, M., Vanbever, R., & Ehrhardt, C. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0836 · Cited by 238
Vandamme (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1045 · Cited by 238
Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis
Nemmar, A., Hoylaerts, M. F., Hoet, P. H. M., Vermylen, J., & Nemery, B. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00024-8 · Cited by 237
Inhaled nano- and microparticles for drug delivery
El-Sherbiny, I. M., El-Baz, N. M., & Yacoub, M. H. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.2 · Cited by 236
Controlled Pulmonary Drug Delivery
(2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6 · Cited by 231
Cytotoxic Impacts of Linear and Branched Polyethylenimine Nanostructures in A431 Cells
Kafil, V., & Omidi, Y. (2011) · Tabriz University of Medical Sciences · doi:10.5681/bi.2011.004 · Cited by 215
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Kaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 190
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
Lee, W.-H., Loo, C.-Y., Traini, D., & Young, P. M. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.08.009 · Cited by 189
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA
Jensen, D. K., Jensen, L. B., Koocheki, S., Bengtson, L., Cun, D., Nielsen, H. M., & Foged, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.011 · Cited by 189
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
Zarogoulidis, P., Zarogoulidis, K., Domvri, Goldberg, Karamanos, Schmidt, & Chatzaki (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29997 · Cited by 185
Pulmonary Drug Metabolism, Clearance, and Absorption
Olsson, B., Bondesson, E., Borgström, L., Edsbäcker, S., Eirefelt, S., Ekelund, K., Gustavsson, L., & Hegelund-Myrbäck, T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_2 · Cited by 183
Verschraegen, C. F., Gilbert, B. E., Loyer, E., Huaringa, A., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
Roa, W. H., Azarmi, S., Al-Hallak, M. H. D. K., Finlay, W. H., Magliocco, A. M., & Löbenberg, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.035 · Cited by 181
Kim, I., Byeon, H. J., Kim, T. H., Lee, E. S., Oh, K. T., Shin, B. S., Lee, K. C., & Youn, Y. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.018 · Cited by 180
Molecular Targeting of Drug Delivery Systems to Cancer
Minko, T., Dharap, S., Pakunlu, R., & Wang, Y. (2004) · Current Drug Targets · doi:10.2174/1389450043345443 · Cited by 175
Nanotechnology-based inhalation treatments for lung cancer: state of the art
Akhter, S., Ahmad, J., Rizwanullah, M., Rahman, M., Zaki Ahmad, M., Rizvi, M. M. A., Ahmad, F. J., Amin, S., & Kamal, M. A. (2015) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s49052 · Cited by 174
Gill, K. K., Nazzal, S., & Kaddoumi, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.017 · Cited by 173
The Microenvironment of Lung Cancer and Therapeutic Implications
Mittal, V., Rayes, T. E., Narula, N., McGraw, T. E., Altorki, N. K., & Barcellos‐Hoff, M. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_5 · Cited by 170
Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs
Elzoghby, A. O., Elgohary, M. M., & Kamel, N. M. (2015) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2014.12.002 · Cited by 170
Self-citationFormulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
AZARMI, S., TAO, X., CHEN, H., WANG, Z., FINLAY, W., LOBENBERG, R., & ROA, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.052 · Cited by 169
Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung
Wittgen, B. P. H., Kunst, P. W. A., van der Born, K., van Wijk, A. W., Perkins, W., Pilkiewicz, F. G., Perez-Soler, R., Nicholson, S., Peters, G. J., & Postmus, P. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1480 · Cited by 166
Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting
Tseng, C.-L., Wang, T.-W., Dong, G.-C., Yueh-Hsiu Wu, S., Young, T.-H., Shieh, M.-J., Lou, P.-J., & Lin, F.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.006 · Cited by 160
Lung Clearance of Inhaled Insoluble and Soluble Particles
OBERDÖRSTER, G. (1988) · Journal of Aerosol Medicine · doi:10.1089/jam.1988.1.289 · Cited by 157
Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
Choi, S. H., Byeon, H. J., Choi, J. S., Thao, L., Kim, I., Lee, E. S., Shin, B. S., Lee, K. C., & Youn, Y. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.008 · Cited by 156
Koshkina, N. V., Waldrep, J. C., Roberts, L., Golunski, E., Melton, S., & Knight, V. (2001) · PubMed · Cited by 154
Tseng, C., Wu, S. Y.-H., Wang, W.-H., Peng, C., Lin, F., Lin, C.-C., Young, T., & Shieh, M.-J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.03.033 · Cited by 150
Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging
Elzoghby, A. O., Hemasa, A. L., & Freag, M. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.023 · Cited by 145
Self-citationAlipour, S., Montaseri, H., & Tafaghodi, M. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.07.050 · Cited by 144
Gagnadoux, F., Hureaux, J., Vecellio, L., Urban, T., Pape, A. L., Valo, I., Montharu, J., Leblond, V., Boisdron‐Celle, M., Lerondel, S., et al. (2008) · Journal of Aerosol Medicine · doi:10.1089/jamp.2007.0656 · Cited by 144
Spray freeze drying for dry powder inhalation of nanoparticles
Ali, M. E., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.009 · Cited by 143
Inoue, K., Takano, H., Yanagisawa, R., Hirano, S., Sakurai, M., Shimada, A., & Yoshikawa, T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8903 · Cited by 143
Anabousi, S., Bakowsky, U., Schneider, M., Huwer, H., Lehr, C., & Ehrhardt, C. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.07.004 · Cited by 141
Kim, I., Byeon, H. J., Kim, T. H., Lee, E. S., Oh, K. T., Shin, B. S., Lee, K. C., & Youn, Y. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.018 · Cited by 139
Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect
Videira, M., Almeida, A. J., & Fabra, À. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.007 · Cited by 138
Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs
Otterson, G. A., Villalona-Calero, M. A., Sharma, S., Kris, M. G., Imondi, A. R., Gerber, M. C., White, D. A., Ratain, M. J., Schiller, J. H., Sandler, A. B., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1096 · Cited by 136
Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes
Witzmann, F. A., & Monteiro-Riviere, N. A. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.07.005 · Cited by 131
Jiang, H., Xu, C., Kim, Y.-K., Arote, R. B., Jere, D., Lim, H.-T., Cho, M., & Cho, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.017 · Cited by 124
Brzoska, M., Langer, K., Coester, C., Loitsch, S. M., Wagner, T. O. F., & von Mallinckrodt, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.067 · Cited by 122
Garbuzenko, O. B., Mainelis, G., Taratula, O., & Minko, T. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.004 · Cited by 121
Nanotechnology and Nanotoxicology
Curtis, J. A., Greenberg, M., Kester, J. E., Phillips, S., & Krieger, G. R. (2006) · Toxicological Reviews · doi:10.2165/00139709-200625040-00005 · Cited by 120
Xu, C., Wang, P., Zhang, J., Tian, H., Park, K., & Chen, X. (2015) · Small · doi:10.1002/smll.201501034 · Cited by 120
Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes
Gaber, M. K., Medhat, W., Hany, M., Saher, N., Fang, J., & Elzoghby, A. O. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.392 · Cited by 120
Self-citationHitzman, C. J., Elmquist, W. F., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20591 · Cited by 119
Gill, S., Löbenberg, R., Ku, T., Azarmi, S., Roa, W., & Prenner, E. J. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.015 · Cited by 118
Anderson, P. M., Markovic, S. N., Sloan, J. A., Clawson, M. L., Wylam, M. E., Arndt, C. A. S., Smithson, W. A., Burch, P. A., Gornet, M. E., & Rahman, E. (1999) · PubMed · Cited by 118
Beck‐Broichsitter, M., Ruppert, C., Schmehl, T., Guenther, A., Betz, T., Bakowsky, U., Seeger, W., Kissel, T., & Gessler, T. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.007 · Cited by 116
Meenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.012 · Cited by 115
Otterson, G. A., Villalona-Calero, M. A., Hicks, W. J., Pan, X. J., Ellerton, J. A., Gettinger, S. N., & Murren, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3015 · Cited by 112
Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Elzoghby, A. O., Elwakil, M. M. A., Abd-Elsalam, K., Elsayed, M. T., Hashem, Y., & Mohamed, O. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160204120829 · Cited by 111
Self-citationDailey, L. A., Wittmar, M., & Kissel, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.003 · Cited by 108
Woods, A., Patel, A., Spina, D., Riffo‐Vasquez, Y., Morgan, A. B., de Rosales, R. T. M., Sunassee, K., Clark, S. K., Collins, H., Bruce, K., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.269 · Cited by 105
Emerging applications of nanoparticles for lung cancer diagnosis and therapy
Sukumar, U. K., Bhushan, B., Dubey, P., Matai, I., Sachdev, A., & Packirisamy, G. (2013) · International nano letters. · doi:10.1186/2228-5326-3-45 · Cited by 105
Li, Y., Sun, X., Gong, T., Liu, J., Zuo, J., & Zhang, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0201-z · Cited by 103
Xu, C., Jere, D., Jin, H., Chang, S.-H., Chung, Y.-S., Shin, J., Kim, J., Park, S. J., Lee, Y.-H., Chae, C., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1022oc · Cited by 102
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina, N. V., Kleinerman, E. S., Waidrep, C., Jia, S.-F., Worth, L. L., Gilbert, B. E., & Knight, V. (2000) · PubMed · Cited by 101
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel
Hureaux, J., Lagarce, F., Gagnadoux, F., Vecellio, L., Clavreul, A., Roger, E., Kempf, M., Racineux, J.-L., Diot, P., & Benoît, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.013 · Cited by 100
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0897-z · Cited by 100
Self-citationFeasibility and effectiveness of inhaled carboplatin in NSCLC patients
Zarogoulidis, P., Eleftheriadou, E., Sapardanis, I., Zarogoulidou, V., Lithoxopoulou, H., Kontakiotis, T., Karamanos, N. K., Zachariadis, G. A., Mabroudi, M., Zisimopoulos, A., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9714-5 · Cited by 96
Jin, H., Kim, T. H., Hwang, S., Chang, S.-H., Kim, H., Anderson, H. K., Lee, H.-W., Lee, K.-H., Colburn, N. H., Yang, H., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0433 · Cited by 96
Xie, Y., Aillon, K. L., Cai, S., Christian, J. M., Davies, N. M., Berkland, C. J., & Forrest, M. L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.058 · Cited by 93
Elzoghby, A. O., Helmy, M. W., Samy, W. M., & Elgindy, N. A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.005 · Cited by 93
Self-citationSarlo, K. T., Blackburn, K. L., Clark, E. D., Grothaus, J., Chaney, J., Neu, S. M., Flood, J. A., Abbott, D., Bohne, C., Casey, K., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.07.002 · Cited by 93
Stocke, N. A., Meenach, S. A., Arnold, S. M., Mansour, H. M., & Hilt, J. Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.050 · Cited by 91
Lung Cancer and Personalized Medicine
Ahmad, A., & Gadgeel, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24223-1 · Cited by 91
Jyoti, K., Kaur, K., Pandey, R. S., Jain, U. K., Chandra, R., & Madan, J. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.12.092 · Cited by 90
Harush-Frenkel, O., Bivas‐Benita, M., Nassar, T., Springer, C., Sherman, Y., Avital, A., Altschuler, Y., Borlak, J. T., & Benita, S. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.011 · Cited by 89
Topical non-invasive gene delivery using gemini nanoparticles in interferon-γ-deficient mice
Badea, I., Wettig, S. D., Verrall, R. E., & Földvári, M. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.002 · Cited by 89
Arndt, C. A. S., Koshkina, N., Inwards, C. Y., Hawkins, D. S., Krailo, M., Villaluna, D., Anderson, P. M., Goorin, A. M., Blakely, M. L., Bernstein, M. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0662 · Cited by 87
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
Moreno-Sastre, M., Pastor, M., Salomon, C. J., Esquisabel, A., & Pedraz, J. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv192 · Cited by 84
Freag, M. S., Elnaggar, Y. S. R., Abdelmonsif, D. A., & Abdallah, O. Y. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0236 · Cited by 82
Self-citationMansour, H. M., Meenach, S. A., Vogt, McGarry, Anderson, �., & Hilt, J. Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30724 · Cited by 80
Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration
El-Gendy, N. A., & Berkland, C. J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9886-2 · Cited by 78
Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
Lemarié, É., Vecellio, L., Hureaux, J., Prunier, C., Valat, C., Grimbert, D., Boisdron‐Celle, M., Giraudeau, B., Pape, A. L., Pichon, É., et al. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0872 · Cited by 77
Cagle, P. T., Zhai, Q. “., Murphy, L., & Low, P. S. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0176-oa · Cited by 77
Koshkina, N. V., Gilbert, B. E., Waldrep, J. C., Seryshev, A. B., & Knight, V. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050966 · Cited by 76
Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform
Cortez‐Jugo, C., Qi, A., Rajapaksa, A. E., Friend, J. R., & Yeo, L. Y. (2015) · Biomicrofluidics · doi:10.1063/1.4917181 · Cited by 76
Luo, Y., Zhai, X., Ma, C., Sun, P., Fu, Z., Liu, W., & Xu, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.005 · Cited by 76
Mohtar, N., Taylor, K. M. G., Sheikh, K., & Somavarapu, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.036 · Cited by 76
Gautam, A. K., Densmore, C. L., Melton, S., Golunski, E., & Waldrep, J. C. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700405 · Cited by 71
Jinturkar, K., Anish, C., Kumar, M., Bagchi, T., Panda, A. K., & Misra, A. R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.067 · Cited by 71
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
Kalantarian, P. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12415 · Cited by 70
Long, J., Cheang, T., Zhuo, S.-Y., Zeng, R., Dai, Q., Li, H., & Shi, F. (2014) · Journal of Nanobiotechnology · doi:10.1186/s12951-014-0037-5 · Cited by 70
Sabra, S. A., Abdelmoneem, M. A., Elwakil, M. M. A., Mabrouk, M. T., Anwar, D. M., Mohamed, R. A., Khattab, S. N., Bekhit, A. A., Elkhodairy, K. A., Freag, M. S., et al. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170526111029 · Cited by 69
Self-citationHitzman, C. J., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20607 · Cited by 68
Chou, A. J., Gupta, R., Bell, M. D., O’Day, K., Meyers, P. A., & Gorlick, R. G. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24438 · Cited by 68
(2003) · PubMed · Cited by 67
Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice
Koshkina, N. V., Golunski, E., Roberts, L., Gilbert, B. E., & Knight, V. (2004) · Journal of Aerosol Medicine · doi:10.1089/089426804322994415 · Cited by 65
Khattab, S. N., Naim, S. E. A., El-Sayed, M., Bardan, A. A. E., Elzoghby, A. O., Bekhit, A. A., & El‐Faham, A. (2016) · New Journal of Chemistry · doi:10.1039/c6nj02539k · Cited by 65
Self-citationDevelopment of controlled-release cisplatin dry powders for inhalation against lung cancers
Levet, V., Rosière, R., Merlos, R., Fusaro, L., Berger, G., Amighi, K., & Wauthoz, N. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.019 · Cited by 65
Elzoghby, A. O., Vranic, B. Z., Samy, W. M., & Elgindy, N. A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.06.015 · Cited by 64
Self-citationExploring targeted pulmonary delivery for treatment of lung cancer
Goel, A., Sahni, J. K., Ali, J., & Baboota, S. (2013) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.108959 · Cited by 62
Minko, T., Kopečková, P., Pozharov, V., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007500412442 · Cited by 62
Zhu, L., Li, M., Liu, X., Du, L., & Jin, Y. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.006 · Cited by 62
Nanoparticle-Mediated Delivery of SiRNA for Effective Lung Cancer Therapy
Kim, Y., Park, T., Singh, B., Maharjan, S., Choi, Y., Choung, P., Arote, R. B., & Cho, C. (2015) · Nanomedicine · doi:10.2217/nnm.14.214 · Cited by 61
Elzoghby, A. O., Saad, N. I., Helmy, M. W., Samy, W. M., & Elgindy, N. A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.003 · Cited by 60
Self-citationKim, H. W., Park, I., Cho, C. S., Lee, K. H., Beck, G. R., Colburn, N. H., & Cho, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1231 · Cited by 56
Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers
Alhallak, K., Sarfraz, M., Azarmi, S., Roa, W., Finlay, W. H., & Löbenberg, R. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.100 · Cited by 55
Jin, H., Cx, X., Kim, H., Chung, Y.-S., Shin, J.-Y., Chang, S.-H., Park, S.-J., Lee, E.-S., Hwang, S.-K., Kwon, J.-T., et al. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701116 · Cited by 55
Zhong, Q., & da Rocha, S. R. P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00876 · Cited by 54
Elfinger, M., Geiger, J. P., Hasenpusch, G., Üzgün, S., Sieverling, N., Aneja, M. K., Maucksch, C., & Rudolph, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.012 · Cited by 53
Biopolymeric Nanoparticles for Oral Protein Delivery: Design and In Vitro Evaluation
Elgindy, N. A., Elkhodairy, K. A., Molokhia, A., & Elzoghby, A. O. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000110 · Cited by 53
Self-citationMagnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery
Upadhyay, D., Scalia, S., Vogel, R., Wheate, N., Salama, R., Young, P. M., Traini, D., & Chrzanowski, W. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0774-9 · Cited by 52
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
Ahmad, A., & Gadgeel, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2 · Cited by 52
Aerosolized Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Therapy in Metastatic Cancer
Rao, R. D., Anderson, P. M., Arndt, C. A. S., et al. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000037664.04141.d0 · Cited by 51
Nemmar, A., Hamoir, J., Nemery, B., & Gustin, P. G. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.012 · Cited by 50
Jiang, H., Hong, S., Kim, Y.-K., Islam, M. A., Kim, H.-J., Choi, Y., Nah, J., Lee, K.-H., Han, K., Chae, C., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.045 · Cited by 48
Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies
Carvalho, T. C., Carvalho, S. R., & McConville, J. T. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0794 · Cited by 47
Novel nanoparticulate systems for lung cancer therapy: an updated review
Madni, A., Batool, A., Noreen, S., Maqbool, I., Rehman, F., Kashif, P. M., Tahir, N., & Raza, A. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1289540 · Cited by 47
Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions
Elgindy, N. A., Elkhodairy, K. A., Molokhia, A., & Elzoghby, A. O. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.539232 · Cited by 46
Self-citationWu, D., Wang, C., Yang, J., Wang, H., Han, H., Zhang, A., Yang, Y., & Li, Q. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00702 · Cited by 45
Alhallak, K., Azarmi, S., Anwar‐Mohamed, A., Roa, W., & Löbenberg, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.002 · Cited by 44
Knight, V., Kleinerman, E. S., Waldrep, J. C., Giovanella, B. C., Gilbert, B. E., & Koshkina, N. V. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07033.x · Cited by 43
Mykhaylyk, O. M., Dudchenko, N. O., & Dudchenko, A. K. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.01.063 · Cited by 43
Aerosol gene delivery using viral vectors and cationic carriers forin vivolung cancer therapy
Hong, S., Park, S. J., Lee, S., Cho, C. S., & Cho, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.986454 · Cited by 43
Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment
Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., Robert Kiss, A., & Amighi, K. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0329-x · Cited by 42
Huland, E., Burger, A., Fleischer, J., Fornara, P., Hatzmann, E., Heidenreich, A., Heinzer, H., Heynemann, H., Hoffmann, L., Hofmann, R., et al. (2003) · Folia Biologica · doi:10.14712/fb2003049050183 · Cited by 42
Shen, J., Chelvam, V., Cresswell, G. M., & Low, P. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006962 · Cited by 40
Nafee, N. A., Schneider, M., Friebel, K., Dong, M., Schaefer, U. F., Mürdter, T. E., & Lehr, C. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.11.019 · Cited by 39
Yang, Y., Cheow, W. S., & Hadinoto, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.036 · Cited by 39
New poly(lactic-co-glycolic acid) derivatives: Modular polymers with tailored properties
Dailey, L. A., & Kissel, T. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.05.017 · Cited by 39
Warheit, D. B., Webb, T., & Reed, K. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-3 · Cited by 39
p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment
Zou, Y., Tornos, C. S., Qiu, X., Lia, M., & Perez-Soler, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0395 · Cited by 38
Taki, M., Tagami, T., Fukushige, K., & Ozeki, T. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.134 · Cited by 38
Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation
Elgindy, N. A., Elkhodairy, K. A., Molokhia, A., et al. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.522190 · Cited by 35
Self-citationTargeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2
Merimsky, O., Gez, E., Weitzen, R., Nehushtan, H., Rubinov, R., Hayat, H. M. S., Peretz, T., Ben-Shahar, M., Biran, H., Katsenelson, R., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh137 · Cited by 35
Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue
Abbas, Y., Azzazy, H. M. E.-S., Tammam, S. N., Lamprecht, A., Ali, M. E., Schmidt, A. M., Sollazzo, S., & Mathur, S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.031 · Cited by 34
Silva, M., Silva, A. S., Fernández‐Lodeiro, J., Casimiro, T., Lodeiro, C., & Aguiar‐Ricardo, A. (2017) · Materials · doi:10.3390/ma10010074 · Cited by 34
Azarmi, S., Löbenberg, R., Roa, W., Tai, S., & Finlay, W. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802149079 · Cited by 33
Overcoming Lung Clearance Mechanisms for Controlled Release Drug Delivery
El-sherbiny, I. M., Guzman‐Villanueva, D., Herrera‐Ruiz, D., & Smyth, H. D. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_5 · Cited by 32
Posch, C., Weihsengruber, F., Bartsch, K., Feichtenschlager, V., Sanlorenzo, M., Vujic, I., Itzinger-Monshi, B., Ortiz‐Urda, S., & Rappersberger, K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.62 · Cited by 30
A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma
Markovic, S. N., Suman, V. J., Nevala, W. K., Geeraerts, L., Creagan, E. T., Erickson, L. A., Rowland, K. M., Morton, R. F., Horvath, W. L., & Pittelkow, M. R. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318173a536 · Cited by 28
Xu, C., Tian, H., Sun, H. Y., Jiao, Z., Zhang, Y., & Chen, X. (2015) · RSC Advances · doi:10.1039/c5ra21934e · Cited by 28
Dong, M., Mürdter, T. E., Philippi, C., Loretz, B., Schaefer, U. F., Lehr, C., Schwab, M. G., & Ammon-Treiber, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.022 · Cited by 27
Distribution of Effervescent Inhalable Nanoparticles After Pulmonary Delivery: an In Vivo Study
Alhallak, K., Sarfraz, M., Azarmi, S., Roa, W., Finlay, W. H., Rouleau, C., & Löbenberg, R. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.42 · Cited by 26
Rosière, R., Gelbcke, M., Mathieu, V., Antwerpen, P. V., Amighi, K., & Wauthoz, N. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3092 · Cited by 25
Kim, Y.-K., Cho, C., Cho, M., & Jiang, H. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34905 · Cited by 24
Triggered-release nanocapsules for drug delivery to the lungs
Chana, J., Forbes, B., & Jones, S. A. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.07.012 · Cited by 21
Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates
Rohani, S., Ragab, D., & Costa (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30190 · Cited by 16
Dixit, M., & Kulkarni, P. K. (2012) · PubMed · Cited by 13
Dual expression of shAkt1 and Pdcd4 suppresses lung tumorigenesis in K-rasLA1 mice.
Hong, S., Lee, J. H., Jiang, H., Kim, J., Lee, A. Y., Kim, S., Cho, C., & Cho, M. (2015) · PubMed · Cited by 12
Ragab, D., & Rohani, S. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9980-y · Cited by 7
Cited by
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Xu, M., Qi, Y., Liu, G., Song, Y., Jiang, X., & Du, B. (2023) · ACS Nano · doi:10.1021/acsnano.3c05853 · Cited by 632
Metal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
Advances and challenges in the treatment of lung cancer
Li, Y., Yan, B., & He, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115891 · Cited by 462
Metadata
- Authors
- Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., Elkhodairy, K. A., Fang, J.-Y., & Elzoghby, A. O.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 269
- Pages
- 374-392
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2770767649
- Cited by
- 409
- References
- 190
- FWCI
- 27.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.